TbGPI16 is an essential component of GPI transamidase in Trypanosoma brucei  by Hong, Yeonchul et al.
FEBS Letters 580 (2006) 603–606TbGPI16 is an essential component of GPI transamidase
in Trypanosoma brucei
Yeonchul Hong, Kisaburo Nagamune, Kazuhito Ohishi, Yasu S. Morita, Hisashi Ashida,
Yusuke Maeda, Taroh Kinoshita*
Department of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan
Received 17 November 2005; revised 18 December 2005; accepted 22 December 2005
Available online 4 January 2006
Edited by Sandro SonninoAbstract Glycosylphosphatidylinositol (GPI) is widely used by
eukaryotic cell surface proteins for membrane attachment. De
novo synthesized GPI precursors are attached to proteins post-
translationally by the enzyme complex, GPI transamidase.
TbGPI16, a component of the trypanosome transamidase, shares
similarity with human PIG-T. Here, we show that TbGPI16 is
the orthologue of PIG-T and an essential component of GPI
transamidase by creating a TbGPI16 knockout. TbGPI16 forms
a disulﬁde-linked complex with TbGPI8. A cysteine to serine
mutant of TbGPI16 was unable to fully restore the surface
expression of GPI-anchored proteins upon transfection into the
knockout cells, indicating that its disulﬁde linkage with TbGPI8
is important for the full transamidase activity.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Intermolecular disulﬁde bond1. Introduction
Many eukaryotic cell surface proteins are tethered to the
plasma membrane via glycosylphosphatidylinositol (GPI).
The GPI anchor is synthesized in the ER by many diﬀerent en-
zymes, which sequentially transfer sugars and ethanolamine
phosphate to phosphatidylinositol. After synthesis, the GPI
anchor is attached to the protein by GPI transamidase before
being transported to the cell surface [1–4]. GPI transamidase
recognizes and cleaves the signal sequence at the C-terminus
of nascent proteins, and replaces it with the preassembled
GPI anchor. In humans, GPI transamidase comprises at least
ﬁve polypeptides (GAA1, GPI8, PIG-S, PIG-T and PIG-U)
[5,6]. Because mammalian cells express a large repertoire of
GPI-anchored proteins, the GPI transamidase must recognize
diverse structurally diﬀerent proteins [7,8]. However, the cell
surface density of GPI anchored proteins is generally not high
in mammalian cells. In a striking contrast, the cell surface of
the protozoan parasite Trypanosoma brucei, which causes
sleeping sickness in Africa, is densely coated predominantlyAbbreviation: GPI, glycosylphosphatidylinositol
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doi:10.1016/j.febslet.2005.12.075by a single species of GPI-anchored proteins speciﬁc to its life
cycle stages [9–14]. The bloodstream form that resides extracel-
lularly in the human bloodstream covers its entire surface with
a GPI-anchored protein termed variant surface glycoprotein
[11,15,16]. In contrast, the procyclic form of the parasite that
propagates in the midgut of the tsetse ﬂy vector protects the
cell surface against the tsetse ﬂy’s digestive system with a dense
coat of a two species of GPI-anchored proteins called procyc-
lins [11,13]. Therefore, the trypanosome GPI transamidase
processes limited kinds of proteins. The GPI attachment signal
sequences of trypanosome proteins do not function well in
mammalian cells [17], indicating that trypanosome and mam-
malian GPI transamidases have diﬀerent speciﬁcities.
In addition to these diﬀerences, the GPI precursors to be rec-
ognized by the GPI transamidase are structurally diﬀerent in
that mammalian GPIs have mannose residues that are modi-
ﬁed by extra ethanolamine phosphates. These observations
suggest that humans and trypanosomes have GPI transamid-
ases of diﬀerent speciﬁcities. In fact, while three components
of trypanosomal transamidase (TbGAA1, TbGPI8 and
TbGPI16) are homologous to human components (GAA1,
GPI8 and PIG-T, respectively), two other components
(TTA1 and TTA2) are unique to the trypanosome enzyme
[6]. Because GPI-anchored proteins play critical roles in the life
cycle of T. brucei, the biosynthesis of GPI-anchored proteins is
a potential drug target [13,18–21]. GPI transamidase reaction
represents a critical step in the biosynthetic pathway, and is
suggested to have diﬀerent speciﬁcities between trypanosomes
and human, making it an enzyme of choice for the develop-
ment of anti-trypanosomal drugs.
It has been shown that GPI8 (TbGPI8 in trypanosome) is
the catalytic component responsible for cleavage of GPI-
attachment signal sequences [22–28] and PIG-T stabilizes the
enzyme complex [5,6]. We have reported that human PIG-T
is linked to GPI8 by a disulﬁde bond and these cysteine resi-
dues are conserved in trypanosomes [29]. Here, we demon-
strate that TbGPI16 is an essential component of GPI
transamidase and forms a disulﬁde bridge with TbGPI8.2. Materials and methods
2.1. Cell culture and gene disruption
Procyclic cells (strain 427) were grown in SDM-79 supplemented
with 10% fetal bovine serum and were transfected with a TbGPI16 5 0
and 3 0 ﬂanking fragment (ClaI PstI fragment) which contained a neo-
mycin (NEO) or blasticidin (BSD) resistance gene. After transfection
of each fragment, heterozygous clones were selected by neomycin orblished by Elsevier B.V. All rights reserved.
Fig. 1. Knockout of TbGPI16 in T. brucei. (A) A restriction map of
TbGPI16 and its ﬂanking regions and two targeting constructs in
which TbGPI16 was replaced with NEO and BSD are shown. A probe
for Southern blotting and predicted fragments detected with this probe
are indicated below the restriction map. (B) Southern blot analysis of
wild-type 427 cells (lane 1), heterozygous clones (lane 2, BSD and lane
3, NEO) and homozygous clone (lane 4, /). Expected positions of
wild-type (5.9 kb) and homologous recombinant fragments (4.6 and
4.2 kb) are indicated on the right.
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clones. Southern blot analysis was carried out with NsiI digested geno-
mic DNA of heterozygous and homozygous clones to conﬁrm homol-
ogous recombinations. The FLAG-GST double tagged wild type
TbGPI16 was cloned into KpnI and BamHI sites of pTMCSzeo [29].
The cysteine-to-serine mutant of TbGPI16 was made with a Quick-
change site-directed mutagenesis kit (Stratagene). TbGPI16 knockout
procyclics were transfected with the resulting plasmids by electropora-
tion and selected using 5 lg/ml Zeocin (Invitrogen).
2.2. Flow cytometric analysis
Trypanosomes were incubated with anti-EP procyclin antibody
(Cedarlane Laboratories), diluted to 2 lg/ml in TDB [20 mM Na2-
HPO4, 2 mM NaH2PO4, 80 mM NaCl, 5 mM KCl, 1 mM MgSO4
and 20 mM glucose] (pH 7.7) containing 1% BSA (1 h, 4 C). After
incubation with the primary antibody the cells were washed twice with
TDB and incubated with ﬂuorescein-5-isothiocyanate-conjugated anti-
mouse IgG (ICN pharmaceuticals), diluted to 2 lg/ml in TDB-1% BSA
(30 min, 4 C). After incubation, the cells were washed twice with TDB
and analyzed in a FACScaliber (BD Biosciences).
2.3. GPI biosynthesis analysis
Hypotonic cell lysate was prepared as described previously, except
that the tunicamycin treatment was omitted [30]. Frozen cell lysate
was thawed and washed twice with 10 volumes of HKMTL buﬀer
[50 mM HEPES (pH 7.4), 25 mM KCl, 5 mM MgCl2, 0.1 mM Na-p-
tosyl-L-lysine chloromethyl ketone and 1.0 lg/ml leupeptin] by centri-
fugation (6000 · g, 10 min, 4 C). The membrane pellet was suspended
at 109 cell equivalents/ml with HKMTL buﬀer supplemented with
5 mM MnCl2, 1 mM dithiothreitol and 0.8 lg/ml tunicamycin. The
labeling and the extraction of glycolipids were performed as described
previously [21].
2.4. Analysis of protein complex
To analyze the formation of the disulﬁde bond between TbGPI8 and
TbGPI16, cells were pretreated for 30 min on ice in phosphate-buﬀered
saline containing 20 mM N-ethylmaleimide (NEM), a membrane-
permeable alkylating reagent that traps disulﬁde formed within cells
and prevents their rearrangement during and after lysis. Cells were
lysed in Nonidet P-40 lysis buﬀer (50 mM Tris–HCl, 5 mM EDTA,
150 mM NaCl and 1% Nonidet P-40, pH 7.5) containing 20 mM
NEM. When cells transfected with FLAG-GST-tagged TbGPI16 were
used, FLAG-GST-tagged TbGPI16 was precipitated with anti-FLAG
M2 agarose (Sigma) and Western blotted with anti-GST antibody
(Amersham Biosciences) or anti-TbGPI8 monoclonal antibody [6].
When non-transfected cells were used, TbGPI8 was precipitated with
anti-TbGPI8 monoclonal antibody plus Protein G Sepharose and
Western blotted with biotinylated-anti-TbGPI8 monoclonal antibody
plus streptavidin–HRP conjugate.
2.5. Pulse-chase analysis of EP-procyclin
Wild-type 427 and TbGPI16 knockout procyclics were pulse labeled
for 30 min at 27 C with [14C] proline in SDM-79 with low proline as
described previously [21]. After chase for various time periods, EP-
procyclin was immunoprecipitated and analyzed by SDS–PAGE and
phosphoimaging.3. Results and discussion
3.1. Construction and characterization of the TbGPI16 knockout
trypanosome
We reported that TbGPI16 has signiﬁcant amino acid se-
quence homology to human PIG-T (13% identity and 25%
similarity) and share similar structural characteristics, the N-
terminal signal sequence and one transmembrane domain near
the C terminus [6]. To determine whether TbGPI16 is a func-
tional component of GPI transamidase, we knocked out the
TbGPI16 gene by replacement with a NEO or BSD resistance
gene in the procyclic form of T. brucei (Fig. 1A). Deletion ofTbGPI16 by homologous recombination was assessed by
Southern blot hybridization (Fig. 1B). A 5.9 kb NsiI fragment
was detected in wild-type T. brucei corresponding to the two
TbGPI16 alleles (Fig. 1B, lane 1). One TbGPI16 allele re-
mained in each heterozygote (lanes 2 and 3). Upon deletion
of the second allele, the TbGPI16 gene could no longer be de-
tected (lane 4), indicating that both alleles of TbGPI16 had
been replaced with NEO or BSD. The knockout parasite had
a similar morphological shape to the wild type, although their
growth rate was slower than the latter.
We then examined the expression of EP-procyclins, a major
GPI-anchored coat protein of the procyclic form of trypano-
somes, on the surface of this knockout by FACS analysis.
TbGPI16 knockout cells completely failed to express procyc-
lins on the surface (Fig. 2A). Transfection with TbGPI16 into
these knockout cells restored surface expression to a level sim-
ilar to that of wild type.
To conﬁrm that the loss of the surface EP-procyclin was not
due to a lack or a decrease in synthesis of EP-procyclin, we
analyzed EP-procyclin by pulse-chase experiment. Proline-
labeled EP-procyclin was generated in TbGPI16 knockout
cells at a level comparable to that in wild-type cells
(Fig. 2B). During chase, EP-procyclin band in the wild-type
cells became broad due to the modiﬁcation of GPI as expected,
whereas EP-procyclin in TbGPI16 knockout gradually disap-
peared due to a lack of GPI attachment.
We then examined GPI biosynthesis in TbGPI16 knockout.
Hypotonically lysed cells were incubated with tritiated GDP-
mannose, and mannolipids were analyzed by TLC. The pro-
ﬁles of intermediates were similar between wild type and the
knockout mutant. The TbGPI16 knockout generated PP1
Fig. 2. Characterization of the TbGPI16 knockout T. brucei. (A)
FACS analysis on the surface expression of EP-procyclin on the
TbGPI16 knockout and the knockout transfected with TbGPI16. (B)
Pulse-chase analysis of EP-procyclin. Wild-type and TbGPI16 knock-
out procyclics were labeled with [14C] proline for 30 min and chased for
indicated time periods. At each time point, EP-procyclin was immu-
noprecipitated and analyzed by SDS–PAGE and phosphoimaging. (C)
High performance TLC analysis of GPI biosynthesis of the TbGPI16
knockout. Wildtype (427), TbGPI16 knockout (KO) and knockout
transfected with TbGPI16 (+TbGPI16). O, origin, F, front.
Fig. 3. Protein complex formation and procyclin restoration with
cysteine mutant of TbGPI16. (A) After transfection of FLAG-GST
tagged TbGPI16 into the knockout, the GPI transamidase complex
was puriﬁed with anti-FLAG agarose. The sample was divided into
two parts, mixed with SDS sample buﬀer with DTT (reducing) or
without DTT (non-reducing) and analyzed by SDS–PAGE, and
Western blotting using anti-TbGPI8 monoclonal antibody. A faint
band seen between 75 and 100 kDa positions under non-reducing
condition is of unknown origin. (B) From wild-type 427 cells, TbGPI8
was immunoprecipitated with anti-TbGPI8 and was analyzed under
non-reducing and reducing conditions by Western blotting with anti-
TbGPI8. (C) and (D) Transfection of the empty vector as a control,
TbGPI16 wild type and Cys-to-Ser mutant C239S into the TbGPI16
knockout. GPI transamidase complexes puriﬁed using FLAG M2
agarose were electrophoresed under non-reducing conditions and
detected by Western blotting with anti-GST (C) and anti-TbGPI8 (D)
antibodies. (E) The analysis of the surface procyclin expression on the
strains transfected with wild-type TbGPI16 and its C239S mutant.
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[31,32], indicating that GPI precursor biosynthesis was unaf-
fected (Fig. 2C). This result, taken together with the deﬁcient
cell surface procyclin expression, indicates that TbGPI16 is
an essential component of GPI transamidase.
3.2. Protein complex analysis of TbGPI16 with TbGPI8
We previously reported that the trypanosome transamidase
complex members, TbGAA1, TbGPI8, TbGPI16, TTA1 and
TTA2, were co-puriﬁed with FLAG- and GST-tagged TbGPI8
by a two-step aﬃnity puriﬁcation using anti-FLAG and gluta-
thione beads [6]. TbGPI16 is predicted to be a 75-kDa type I
membrane protein [6], with a putative signal peptide cleavage
site between positions 19 and 20. In this study, to identify a
component covalently linked with TbGPI16, we transfected
C-terminally FLAG-GST-tagged TbGPI16 gene into the
TbGPI16 knockout. Transamidase complexes puriﬁed by
immunoprecipitation with anti-FLAG were analyzed by Wes-
tern blot using anti-TbGPI8 monoclonal antibody. Under
non-reducing conditions, Western blotting with anti-TbGPI8
monoclonal antibody showed an intense 150-kDa band
(Fig. 3A). When the sample was analyzed under reducing con-
ditions, this high molecular mass band disappeared and only aband of about 37-kDa was detected in the wild-type TbGPI16
gene transfectants, which corresponded to the molecular
weight of TbGPI8, suggesting that the high molecular band
is a disulﬁde-linked complex of TbGPI16 and TbGPI8.
To determine whether TbGPI8 is always disulﬁde-linked to
TbGPI16 or some TbGPI8 is not disulﬁde-linked to TbGPI16,
we immunoprecipitated TbGPI8 from non-transfected cells.
As shown in Fig. 3B. most, if not all, of the TbGPI8 was
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could be washed out from the ER membrane by high pH
[33]. Since TbGPI8 has no transmembrane domain, it may be
dissociated from the protein complex if disulﬁde linkage to
TbGPI16 is cleaved. It seems possible that under high pH disul-
ﬁde exchange occurred resulting in dissociation of TbGPI8.
We reported that human GPI8 is disulﬁde-linked to Cys182
of PIG-T [29]. Cys182 of PIG-T corresponded to conserved
Cys239 of TbGPI16, suggesting that Cys239 is involved in
the disulﬁde linkage with TbGPI8. To determine the cysteine
residue involved in disulﬁde bond, we constructed cysteine-
to-serine mutants of TbGPI16 (C239S). GPI transamidase
components were puriﬁed using anti-FLAG agarose (Sigma)
from the transfectant with FLAG-GST tagged TbGPI16 or
its cysteine-to-serine mutant (C239S) and detected by Western
blot using anti-GST or anti-TbGPI8 antibodies. The 150-kDa
band, which reacted with anti-GST antibody, was seen in the
wild type, whereas the C239S mutant did not form this high
molecular weight covalent complex (Fig. 3C). While wild type
TbGPI16 was disulﬁde linked to TbGPI8 as shown by the po-
sitive anti-TbGPI8 antibody signal, the mutant TbGPI16 did
not form complexes with TbGPI8 as demonstrated by the ab-
sence of an anti-TbGPI8 antibody signal (Fig. 3D), indicating
that TbGPI16 is disulﬁde linked to TbGPI8 through cysteine
239 of TbGPI16. Since TbGPI8 lacks the C-terminal trans-
membrane domain, which is present in human GPI8
[22,26,27], either TbGPI8 or TbGPI16 may be dissociated
from the transamidase complex due to a weak interaction with
other components of GPI transamidase during the immuno-
precipitation processes.
3.3. The expression of EP procyclin on the surface of C239S
mutant trypanosome
To examine whether the disulﬁde linkage is important for
the GPI transamidase activity, we determined the abilities of
these transfectants to restore the surface expression of EP-
procyclin. Wild-type TbGPI16 transfectant restored the sur-
face procyclin expression of this knockout cells, whereas
C239S mutants restored it at a signiﬁcant lower level
(Fig. 3E). Therefore, the formation of the disulﬁde bond is
not essential but required for full transamidase activity, sug-
gesting its role in assisting the proper positioning of these
two components and/or stabilization of the complex. These
structural characteristics were conserved between trypano-
somes and human transamidases.
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